Moore Law, PLLC Encourages Dollar Tree, Inc. Investors to Contact Law Firm
Moore Law, PLLC Encourages Dollar Tree, Inc. Investors to Contact Law Firm
PR Newswire
NEW YORK, March 13, 2024
NEW YORK, March 13, 2024 /PRNewswire/ -- Moore Law, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against:
- Dollar Tree, Inc. ("Dollar Tree" or "the Company") (NASDAQ: DLTR)
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Dollar Tree is the subject of a report by Bloomberg published on March 13, 2024. According to the report, the Company "plans to shutter about 1,000 stores in an effort to improve profitability as the discount retailer battles a spate of litigation and other headwinds." Based on this news, shares of Dollar Tree fell by more than 15% in morning trading on the same day.
If you own Dollar Tree, Inc. (NASDAQ: DLTR) please contact Fletcher Moore by email at fletcher@fmoorelaw.com.
There is no cost to you. We will never send you a bill or ask for payment.
ABOUT MOORE LAW
Moore Law gives investors a voice. We hold officers and directors accountable for breaches of fiduciary duty, inside selling, and other corporate malfeasance. We strengthen corporate governance reforms giving your investments the protection they deserve.
Attorney advertising. Prior results do not guarantee similar outcomes.
Moore Law, PLLC
30 Wall Street, 8th Floor
New York, NY 10005
Fletcher Moore, Esq.
fletcher@fmoorelaw.com
(212) 709-8245
View original content to download multimedia:https://www.prnewswire.com/news-releases/moore-law-pllc-encourages-dollar-tree-inc-investors-to-contact-law-firm-302088536.html
SOURCE Moore Law PLLC
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth